NCT00380354View on ClinicalTrials.gov

Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

June 30, 2007

Conditions
AsthmaMild Asthma
Interventions
DRUG

GSK256066

Trial Locations (2)

M23 9LT

GSK Investigational Site, Manchester

SE1 9RT

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY